Literature DB >> 19913432

Mucin-interacting proteins: from function to therapeutics.

Shantibhusan Senapati1, Srustidhar Das, Surinder K Batra.   

Abstract

Mucins are high molecular weight glycoproteins that are involved in regulating diverse cellular activities both in normal and pathological conditions. Mucin activity and localization is mediated by several molecular mechanisms, including discrete interactions with other proteins. An understanding of the biochemistry behind the known interactions between mucins and other proteins, coupled with an appreciation of their pathophysiological significance, can lend insight into the development of novel therapeutic agents. Indeed, a recent study demonstrated that a cell permeable inhibitor, PMIP, that disrupts the MUC1-EGFR interaction, is effective in killing breast cancer cells in vitro and in tumor models. 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19913432      PMCID: PMC3030310          DOI: 10.1016/j.tibs.2009.10.003

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  63 in total

1.  Involvement of the MAP kinase ERK2 in MUC1 mucin signaling.

Authors:  D Meerzaman; P S Shapiro; K C Kim
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2001-07       Impact factor: 5.464

2.  Transgenic MUC1 interacts with epidermal growth factor receptor and correlates with mitogen-activated protein kinase activation in the mouse mammary gland.

Authors:  J A Schroeder; M C Thompson; M M Gardner; S J Gendler
Journal:  J Biol Chem       Date:  2001-01-22       Impact factor: 5.157

3.  The c-Src tyrosine kinase regulates signaling of the human DF3/MUC1 carcinoma-associated antigen with GSK3 beta and beta-catenin.

Authors:  Y Li; H Kuwahara; J Ren; G Wen; D Kufe
Journal:  J Biol Chem       Date:  2001-01-10       Impact factor: 5.157

4.  The role of Thomsen-Friedenreich antigen in adhesion of human breast and prostate cancer cells to the endothelium.

Authors:  V V Glinsky; G V Glinsky; K Rittenhouse-Olson; M E Huflejt; O V Glinskii; S L Deutscher; T P Quinn
Journal:  Cancer Res       Date:  2001-06-15       Impact factor: 12.701

Review 5.  Structure and biosynthesis of human salivary mucins.

Authors:  A Zalewska; K Zwierz; K Zółkowski; A Gindzieński
Journal:  Acta Biochim Pol       Date:  2000       Impact factor: 2.149

6.  Molecular mapping of statherin- and histatin-binding domains in human salivary mucin MG1 (MUC5B) by the yeast two-hybrid system.

Authors:  I Iontcheva; F G Oppenheim; G D Offner; R F Troxler
Journal:  J Dent Res       Date:  2000-02       Impact factor: 6.116

7.  MUC1 alters beta-catenin-dependent tumor formation and promotes cellular invasion.

Authors:  Joyce A Schroeder; Melissa C Adriance; Melissa C Thompson; Todd D Camenisch; Sandra J Gendler
Journal:  Oncogene       Date:  2003-03-06       Impact factor: 9.867

8.  The cancer antigen CA125 represents a novel counter receptor for galectin-1.

Authors:  Claudia Seelenmeyer; Sabine Wegehingel; Johannes Lechner; Walter Nickel
Journal:  J Cell Sci       Date:  2003-04-01       Impact factor: 5.285

9.  DF3/MUC1 signaling in multiple myeloma cells is regulated by interleukin-7.

Authors:  Yongqing Li; Wen Chen; Jian Ren; Wei-Hsuan Yu; Quan Li; Kiyotsugu Yoshida; Donald Kufe
Journal:  Cancer Biol Ther       Date:  2003 Mar-Apr       Impact factor: 4.742

Review 10.  The cytoplasmic tail of MUC1: a very busy place.

Authors:  Daniel D Carson
Journal:  Sci Signal       Date:  2008-07-08       Impact factor: 8.192

View more
  51 in total

Review 1.  Mucins in the pathogenesis of breast cancer: implications in diagnosis, prognosis and therapy.

Authors:  Partha Mukhopadhyay; Subhankar Chakraborty; Moorthy P Ponnusamy; Imayavaramban Lakshmanan; Maneesh Jain; Surinder K Batra
Journal:  Biochim Biophys Acta       Date:  2011-01-26

Review 2.  Mucins and toll-like receptors: kith and kin in infection and cancer.

Authors:  Shikha Tarang; Sushil Kumar; Surinder K Batra
Journal:  Cancer Lett       Date:  2012-02-03       Impact factor: 8.679

Review 3.  Interaction of extravillous trophoblast galectin-1 and mucin(s)-Is there a functional relevance?

Authors:  Žanka Bojić-Trbojević; Milica Jovanović Krivokuća; Nikola Kolundžić; Toshihiko Kadoya; Ljiljana Radojčić; Ljiljana Vićovac
Journal:  Cell Adh Migr       Date:  2015-09-29       Impact factor: 3.405

Review 4.  Genetically engineered mucin mouse models for inflammation and cancer.

Authors:  Suhasini Joshi; Sushil Kumar; Sangeeta Bafna; Satyanarayana Rachagani; Kay-Uwe Wagner; Maneesh Jain; Surinder K Batra
Journal:  Cancer Metastasis Rev       Date:  2015-12       Impact factor: 9.264

Review 5.  Mucin-based targeted pancreatic cancer therapy.

Authors:  Maria P Torres; Subhankar Chakraborty; Joshua Souchek; Surinder K Batra
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

6.  Novel INTeraction of MUC4 and galectin: potential pathobiological implications for metastasis in lethal pancreatic cancer.

Authors:  Shantibhusan Senapati; Pallavi Chaturvedi; William G Chaney; Subhankar Chakraborty; Vinayaga S Gnanapragassam; Aaron R Sasson; Surinder K Batra
Journal:  Clin Cancer Res       Date:  2010-11-08       Impact factor: 12.531

Review 7.  Emerging potential of natural products for targeting mucins for therapy against inflammation and cancer.

Authors:  Muzafar A Macha; Shiv Ram Krishn; Rahat Jahan; Kasturi Banerjee; Surinder K Batra; Maneesh Jain
Journal:  Cancer Treat Rev       Date:  2015-01-14       Impact factor: 12.111

8.  Binding of transmembrane mucins to galectin-3 limits herpesvirus 1 infection of human corneal keratinocytes.

Authors:  A M Woodward; J Mauris; P Argüeso
Journal:  J Virol       Date:  2013-03-13       Impact factor: 5.103

9.  Analysis of tumor-associated mucin glycotopes by Western transfer methods.

Authors:  Vinayaga S Gnanapragassam; Maneesh Jain; Surinder K Batra
Journal:  Methods Mol Biol       Date:  2013

10.  Cigarette smoke disrupts the integrity of airway adherens junctions through the aberrant interaction of p120-catenin with the cytoplasmic tail of MUC1.

Authors:  Lili Zhang; Marianne Gallup; Lorna Zlock; Carol Basbaum; Walter E Finkbeiner; Nancy A McNamara
Journal:  J Pathol       Date:  2012-09-28       Impact factor: 7.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.